Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Diabetic Nephropathy

被引:81
作者
Arora, Mandeep Kumar [1 ]
Singh, Umesh Kumar [1 ]
机构
[1] Swami Vivekanand Subharti Univ, Fac Pharm, Dept Pharmacol, Meerut 250005, Uttar Pradesh, India
关键词
Anti oxidants; diabetic nephropathy; oxidative stress; ROS generation; signaling pathways; target site; PROTEIN-KINASE-C; VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; RAT MESANGIAL CELLS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; JAK/STAT SIGNALING PATHWAY; NITRIC-OXIDE PRODUCTION; ALPHA-LIPOIC ACID; NF-KAPPA-B;
D O I
10.2174/1389450115666140321120635
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Excessive production of reactive oxygen species is an important mechanism underlying the pathogenesis of diabetes associated macrovascular and microvascular complications including diabetic nephropathy. Diabetic nephropathy is characterized by glomerular enlargement, early albuminuria and progressive glomerulosclerosis. The pathogenesis of diabetic nephropathy is multi-factorial and the precise mechanisms are unclear. Hyperglycemia-mediated dysregulation of various pathways either enhances the intensity of oxidative stress or these pathways are affected by oxidative stress. Thus, oxidative stress has been considered as a central mediator in progression of nephropathy in patients with diabetes. In this review, we have focused on current perspectives in oxidative stress signaling to determine common biological processes whereby diabetes-induced oxidative stress plays a central role in progression of diabetic nephropathy.
引用
收藏
页码:531 / 538
页数:8
相关论文
共 91 条
  • [1] STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells
    Arany, I.
    Megyesi, J. K.
    Nelkin, B. D.
    Safirstein, R. L.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (04) : 669 - 674
  • [2] How hyperglycemia promotes atherosclerosis: molecular mechanisms
    Aronson, Doron
    Rayfield, Elliot J.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2002, 1 (1)
  • [3] Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update
    Arora, Mandeep Kumar
    Singh, Umesh Kumar
    [J]. VASCULAR PHARMACOLOGY, 2013, 58 (04) : 259 - 271
  • [4] Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells
    Babazono, T
    Kapor-Drezgic, J
    Dlugosz, JA
    Whiteside, C
    [J]. DIABETES, 1998, 47 (04) : 668 - 676
  • [5] Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism
    Balakumar, Pitchai
    Arora, Mandeep Kumar
    Reddy, Jayarami
    Anand-Srivastava, Madhu B.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 54 (02) : 129 - 138
  • [6] Recent advances in pharmacotherapy for diabetic nephropathy: Current perspectives and future directions
    Balakumar, Pitchai
    Arora, Mandeep Kumar
    Ganti, Subrahmanya S.
    Reddy, Jayarami
    Singh, Manjeet
    [J]. PHARMACOLOGICAL RESEARCH, 2009, 60 (01) : 24 - 32
  • [7] NAD(P)H Oxidase Mediates TGF-β1-Induced Activation of Kidney Myofibroblasts
    Bondi, Corry D.
    Manickam, Nagaraj
    Lee, Duck Yoon
    Block, Karen
    Gorin, Yves
    Abboud, Hanna E.
    Barnes, Jeffrey L.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (01): : 93 - 102
  • [8] Border, 1998, KIDNEY INT, V54, P1390
  • [9] Boullier A, 2001, ANN NY ACAD SCI, V947, P214
  • [10] Biochemistry and molecular cell biology of diabetic complications
    Brownlee, M
    [J]. NATURE, 2001, 414 (6865) : 813 - 820